| Mylan Pharma GmbH - Erlotinib Mylan 25 mg, Filmtabletten | | 68092 | | 01 | | Erlotinib Mylan 25 mg | | Filmtabletten | | L01XE03 | | Erlotinib | | 09.03.2021 | | |
| | Composition | | erlotinibum 25 mg ut erlotinibi hydrochloridum, lactosum monohydricum 23.98 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydrogenocarbonas, pro compresso obducto corresp. natrium 0.177 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Erlotinib | 25 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Acidi Methacrylici | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Ethylis Acrylatis Polymerisatum | | | | Lactose Monohydrate | 23.98 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Sodium Hydrogen Carbonate | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Talcum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
